Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis

Chemistry and Biology

Volumn 7, Issue 7, 2000, Pages 453-461

  Huang, Chun Ming ^a   Wu, Ying Ta ^a   Chen, Shui Tein ^a  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

Apoptosis; Endocytosis; Octreotide; Paclitaxel; Somatostatin

Indexed keywords

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MINK CELL FOCUS-FORMING VIRUS;

EID: 0033927859     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00131-9     Document Type: Article

References (48)

1. Reichlin, S. (1983). Somatostatin. New Engl. J. Med. 309, 1495-1501, 1556-1563.
2. Schally A.V. Oncological applications of somatostatin analogs. Cancer Res. 48:1988;6977-6985.
3. Lamberts S.W.J., Krenning E.P., Reubi J.C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 12:1991;450-482.
4. Goldstein J.L., Brow M.S., Anderson R.G., Russell D.W., Schneider W.J. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu. Rev. Cell Biol. 1:1985;1-39.
5. Bauer W., Pless J.et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31:1982;1133-1140.
6. 99mTc-P829. Cancer Res. 58:1998;1850-1859.
7. Reubi J.C., Lang W., Maurer R., Koper J.W., Lambert S.W.J. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res. 47:1987;4758-4764.
8. Hoelting T., Duh Q., Clark O.H., Herfarth C. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo. J. Clin. Endocrinol. 15:1996;2638-2641.
9. Raynor K., Reisine T.et al. Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Am. Soc. Pharmacol. Exp. Ther. 16:1993;385-392.
10. Simpkins H., Parekh H. Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Biochem. Pharmacol. 51:1996;301-311.
11. Lambert S.W.J., Krenning E.P., Rebui J.-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 12:1991;450-482.
12. Bakker W.H., Kreening E.P., Breeman W.A.P. In vivo use of a radiolabelled somatostatin analog: dynamics. Metabolism and binding to somatostatin receptor-postive tumors in man. J. Nucl. Med. 33:1991;652-658.
13. Wu Y.-T., Wang K.-T.et al. Facile solid phase synthesis of octreotide analogs p-carboxybenzaldehyde as a linker to anchor Fmoc-threninol to solid phase resins. Tetrahedron Lett. 39:1998;1783-1784.
14. Rowinsky E.K., Onetto N., Canetta R.M., Arbuck S.G. Taxol: The first of the taxanes, an important new class of antitumor agents. Semin. Oncol. 19:1992;646-662.
15. Rowinsky E.K., Donehower R.C. The clinical pharmacology of paclitaxel (taxol). Semin. Oncol. 20:1993;16-25.
16. Liebmann J.E., Mitchell J.B.et al. Cytotoxic studies of paclitaxel (taxol) in human tumor cell lines. Br. J. Cancer. 68:1993;1104-1109.
17. Wani M.C., Taylor H.L., Wall M.E., Coggon P., NcPhail A.T. Plant antitumor agents VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93:1971;2325-2327.
18. Chu J.-J., Lai .Y.-K.et al. Taxol induces concomitant hyperphosphorylation and reorganization of vimentin intermediate filaments in 9L rat brain tumor cells. J. Cell. Biochem. 68:1998;472-483.
19. Horwitz S.B. Mechanism of action of taxol. Trends Pharmacol. Sci. 13:1992;134-136.
20. Hofland L.J., Lamberts S.W.J.et al. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells. Endocrinology. 131:1992;571-577.
21. Hofland L.J., Lamberts W.J.et al. Role of tumor-derived fibroblasts in the growth of primary cultures of human breast-cancer cells: effects of epidermal growth factor and the somatostatin analogue octreotide. Int. J. Cancer. 60:1995;93-99.
22. Setyono-Han B., Henkelman M.S., Foekens J.A., Klijn J.G.M. Direct inhibitory effects of somatostatin (analogs) on the growth of human breast cancer cells. Cancer Res. 47:1987;1566-1570.
23. Sharma K., Srikant C.B. Induction of wild-type p53, BAX, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int. J. Cancer. 76:1998;259-266.
24. O'carroll A.-M., Raynor K., Lolait S.J., Reisine T. Characterization of cloned human somatostatin receptor SSTR5. Mol. Pharmacol. 46:1994;291-298.
25. Gregorakis, S.I., Robertson, L-A., Watson, P. & Patel, Y.C. (1995). MRNA expression of five human somatostatin receptor subtypes (hSSTR1-5) in human breast tumor tissues. International Congress on Somatostatin Analogs: Basic and Clinical Perspectives, Sorrento, Italy. Abstract 9.
26. Sharma K.S., Patel Y.C., Srikant C.B. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol. Endocrinol. 10:1996;1688-1696.
27. 3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. Endocrinology. 136:1995;3698-3706.
28. Bauer W., Pless J.et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31:1982;1133-1140.
29. Manfredi J.J., Parness J., Horwitz S.B. Taxol binds to cellular microtubules. J. Cell Biol. 94:1982;688-696.
30. Seidman A.D., Norton L.et al. Paclitaxel for breast cancer: the memorial Sloan-Kettering cancer center experience. Oncology. 11(3 suppl 2):1997;20-28.
31. Dunton C.J. New options for the treatment of advanced ovarian cancer. Semin. Oncol. 24(1 suppl 5):1997;S5-S2S511.
32. Holmes F.A., Hortobagyi G.N.et al. Phase II study of taxol, an active drug in the treatment of metastatic breast cancer. J. Natl. Cancer Inst. 83:1991;1797-1805.
33. cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ. 5:1994;1041-1050.
34. WAF1 and p53 requires c-raf-1. Cancer Res. 55:1995;4623-4626.
35. Wain M.C., Taylor H.L., Wall M.E., Coogan P.C., McPail A.J. Plant antitumor agents, IV. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93:1971;2325-2327.
36. Nicolaou K.C., Dai W.-M., Guy R.K. Chemistry and biology of taxol. Angew. Chem. Int. Ed. Engl. 33:1994;15-44.
37. Deutsch H.M., Zalkow L.H. Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity. J. Med. Chem. 32:1989;788-792.
38. Mathew A.E., Mejillano M.R., Nath J.P., Himes R.H., Stella V.J. Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity. J. Med. Chem. 35:1992;145-151.
39. Wu Y.-T., Hsieh H.-P., Chen S.-T., Wang K.-T. Direct solid phase synthesis of biologically active peptide alcohols. J. Chin. Chem. Soc. 46:1999;135-138.
40. Bollag D.M., Woods C.M.et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res. 55:1995;2325-2333.
41. Djabali K. Cytoskeletal proteins connecting intermediate filaments to cytoplasmic and nuclear preipery. Histol. Histopathol. 14:1999;501-509.
42. Parekh H., Simpkins H. Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Biochem. Pharmacol. 51:1996;301-311.
43. Weckbecker G., Raulf F., Tolcsvai L., Bruns C. Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo. Digestion. 57(suppl 1):1996;22-28.
44. Nagy A., Kahan Z.et al. Synthesis and biological evalution of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Proc. Natl Acad. Sci. USA. 95:1998;1794-1799.
45. Bayer W., Briner U., Doephner W. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31:1982;1133-1140.
46. Plumb J.A., Milroy R., Kaye S.B. Effect of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 49:1989;4435-4440.
47. Hartfield P.J., Mayne G.C., Murray A.W. Ceramide induces apoptosis in PC12 cells. FEBS Lett. 401:1997;148-152.
48. Hill S.M., Blask D.E. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48:1988;6121-6126.